Denali Oncology Group
EIN: 260900479 · Anchorage, AK · NTEE: G033
| Metric | Value |
|---|---|
| Total Revenue | $105K |
| Total Expenses | $51K |
| Net Assets | $439K |
Is Denali Oncology Group Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About Denali Oncology Group
Denali Oncology Group (EIN: 260900479) is a nonprofit organization based in Anchorage, AK, classified under NTEE code G033. The organization reported total revenue of $105K and total assets of $439K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Denali Oncology Group's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Denali Oncology Group is a small nonprofit that has been operating for 18 years, with 9 years of IRS 990 filings on record (2010–2023). Revenue has grown at a compound annual rate of 8.5%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $105K |
| Total Expenses | $51K |
| Surplus / Deficit | +$54K |
| Total Assets | $439K |
| Net Assets | $439K |
| Operating Margin | 51.1% |
| Months of Reserves | 102.6 months |
Financial Health Grade: A
In 2023, Denali Oncology Group reported a surplus of $54K with revenue exceeding expenses, holds 102.6 months of operating reserves (strong position).
Financial Trends
Over 9 years of filings (2010–2023), Denali Oncology Group's revenue has grown at a compound annual growth rate (CAGR) of 8.5%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +321.5% | +19.2% | +15.0% |
| 2021 | -43.9% | +197.0% | -4.5% |
| 2020 | -58.7% | -82.2% | +8.1% |
| 2019 | +16.2% | +200.6% | +7.6% |
| 2018 | +37.0% | +54.0% | +23.5% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2000 |
| IRS Ruling Date | 2008 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for Denali Oncology Group has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Denali Oncology Group with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $54K, with revenue exceeding expenses.
Frequently Asked Questions about Denali Oncology Group
Is Denali Oncology Group a legitimate charity?
Denali Oncology Group (EIN: 260900479) is a registered tax-exempt nonprofit based in Alaska. It has 9 years of IRS 990 filings on record. Total revenue: $105K. No red flags identified. Financial health grade: A.
How does Denali Oncology Group spend its money?
Denali Oncology Group reported $105K in total revenue in IRS 990 filings. 9 years of filing data available. Revenue exceeded expenses in the most recent year. Review the full spending breakdown on NonprofitSpending.
Are donations to Denali Oncology Group tax-deductible?
Denali Oncology Group is registered as a tax-exempt nonprofit (EIN: 260900479). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is Denali Oncology Group located?
Denali Oncology Group is headquartered in Anchorage, Alaska and files with the IRS under EIN 260900479. It is classified under NTEE code G033.
How many years of IRS 990 filings does Denali Oncology Group have?
Denali Oncology Group has 9 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $105K in total revenue.
Filing History
IRS 990 filing history for Denali Oncology Group showing financial trends over 9 years of public records:
Over 9 years of IRS 990 filings (2010–2023), Denali Oncology Group's revenue has grown by 188.8%, moving from $36K to $105K. Total assets increased by 725.9% over the same period, from $53K to $439K. Total functional expenses rose by 81.5%, from $28K to $51K. In its most recent filing year (2023), Denali Oncology Group reported a surplus of $54K, with revenue exceeding expenses.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $105K | $51K | $439K | $0 | — | — |
| 2021 | $25K | $43K | $381K | $0 | — | View 990 |
| 2020 | $44K | $14K | $399K | $0 | — | — |
| 2019 | $108K | $82K | $370K | $0 | — | View 990 |
| 2018 | $93K | $27K | $344K | $0 | — | View 990 |
| 2017 | $68K | $18K | $278K | $0 | — | View 990 |
| 2016 | $83K | $26K | $228K | $0 | — | View 990 |
| 2015 | $142K | $61K | $172K | $1K | — | View 990 |
| 2010 | $36K | $28K | $53K | $0 | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $105K, expenses of $51K, and assets of $439K (revenue +321.5% year-over-year).
- 2021: Revenue of $25K, expenses of $43K, and assets of $381K (revenue -43.9% year-over-year).
- 2020: Revenue of $44K, expenses of $14K, and assets of $399K (revenue -58.7% year-over-year).
- 2019: Revenue of $108K, expenses of $82K, and assets of $370K (revenue +16.2% year-over-year).
- 2018: Revenue of $93K, expenses of $27K, and assets of $344K (revenue +37.0% year-over-year).
- 2017: Revenue of $68K, expenses of $18K, and assets of $278K (revenue -18.7% year-over-year).
- 2016: Revenue of $83K, expenses of $26K, and assets of $228K (revenue -41.3% year-over-year).
- 2015: Revenue of $142K, expenses of $61K, and assets of $172K (revenue +289.2% year-over-year).
- 2010: Revenue of $36K, expenses of $28K, and assets of $53K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Denali Oncology Group:
Data Sources and Methodology
This transparency report for Denali Oncology Group is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.